FilingReader Intelligence
Haisco Pharmaceutical reports 91% profit jump, ownership change
August 22, 2025 at 08:07 PM UTC•By FilingReader AI
Haisco Pharmaceutical Group reported operating revenue rose 18.63% to 2.00 billion yuan in its half-year results, while net profit attributable to shareholders jumped 90.84% to 144.6 million yuan.
The company announced Wang Junmin as its new controlling shareholder.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
2025 semi-annual financial reportAugust 22, 2025 at 08:00 AM UTC
2025 half-yearly reportAugust 22, 2025 at 08:00 AM UTC
Announcement regarding the use of self-owned funds to pay for part of the proceeds-raising investment project expenses and the equivalent replacement with raised fundsAugust 22, 2025 at 08:00 AM UTC
Special report on the deposit and actual use of raised funds for the first half of 2025August 22, 2025 at 08:00 AM UTC
Summary table of semi-annual non-operating fund appropriation and other related party fund transactionsAugust 22, 2025 at 08:00 AM UTC
SZSE:002653•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Haisco Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime